UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 356

Sortiert nach

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

The Lancet (British edition), 2015-05, Vol.385 (9979), p.1748-1757

2015

Link zum Volltext

Verfügbarkeit prüfen

Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers

Nature Medicine, 2015-03, Vol.21 (3), p.270-275

2015

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

Nature communications, 2017-11, Vol.8 (1), p.1859-8, Article 1859

2017

Link zum Volltext

Verfügbarkeit prüfen

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome

Nature genetics, 2012-05, Vol.44 (5), p.575-580

2012

Link zum Volltext

Verfügbarkeit prüfen

A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model

Molecular therapy, 2017-09, Vol.25 (9), p.2038-2052

2017

Link zum Volltext

Verfügbarkeit prüfen

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Nature communications, 2014-12, Vol.5 (1), p.5515, Article 5515

2014

Link zum Volltext

Verfügbarkeit prüfen

Distinctive serum miRNA profile in mouse models of striated muscular pathologies

PloS one, 2013-02, Vol.8 (2), p.e55281-e55281

2013

Link zum Volltext

Verfügbarkeit prüfen

Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy Patients

The American journal of pathology, 2014-11, Vol.184 (11), p.2885-2898

2014

Link zum Volltext

Verfügbarkeit prüfen

The congenital muscular dystrophies in 2004: a century of exciting progress

Neuromuscular disorders : NMD, 2004-10, Vol.14 (10), p.635-649

2004

Link zum Volltext

Verfügbarkeit prüfen

Lack of Myostatin Results in Excessive Muscle Growth but Impaired Force Generation

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (6), p.1835-1840

2007

Link zum Volltext

Verfügbarkeit prüfen

Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders

American journal of human genetics, 2016-01, Vol.98 (1), p.90-101

2016

Link zum Volltext

Verfügbarkeit prüfen

Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders

Skeletal muscle, 2011-11, Vol.1 (1), p.34-34, Article 34

2011

Link zum Volltext

Verfügbarkeit prüfen

Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping

Molecular therapy, 2012-11, Vol.20 (11), p.2120-2133

2012

Link zum Volltext

Verfügbarkeit prüfen

Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies

Human molecular genetics, 2015-09, Vol.24 (17), p.4916-4932

2015

Link zum Volltext

Verfügbarkeit prüfen

Lamins and nesprin-1 mediate inside-out mechanical coupling in muscle cell precursors through FHOD1

Scientific reports, 2017-04, Vol.7 (1), p.1253-14, Article 1253

2017

Link zum Volltext

Verfügbarkeit prüfen

Repair of Rhodopsin mRNA by Spliceosome-Mediated RNA Trans-Splicing: A New Approach for Autosomal Dominant Retinitis Pigmentosa

Molecular therapy, 2015-05, Vol.23 (5), p.918-930

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C

Brain (London, England : 1878), 2012-02, Vol.135 (2), p.483-492

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review

Nutrients, 2023-08, Vol.15 (16), p.3525

2023

Link zum Volltext

Verfügbarkeit prüfen

Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy

American journal of human genetics, 2017-03, Vol.100 (3), p.537-545

2017

Link zum Volltext

Verfügbarkeit prüfen

A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment

PloS one, 2016-06, Vol.11 (6), p.e0156696-e0156696

2016

Link zum Volltext

Verfügbarkeit prüfen

Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2014-07, Vol.24 (7), p.563-573

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular Dystrophy

American journal of human genetics, 2009-09, Vol.85 (3), p.338-353

2009

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy

Journal of cachexia, sarcopenia and muscle, 2021-06, Vol.12 (3), p.677-693

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(331)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome

A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Distinctive serum miRNA profile in mouse models of striated muscular pathologies

Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy Patients

The congenital muscular dystrophies in 2004: a century of exciting progress

Lack of Myostatin Results in Excessive Muscle Growth but Impaired Force Generation

Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders

Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders

Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping

Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies

Lamins and nesprin-1 mediate inside-out mechanical coupling in muscle cell precursors through FHOD1

Repair of Rhodopsin mRNA by Spliceosome-Mediated RNA Trans-Splicing: A New Approach for Autosomal Dominant Retinitis Pigmentosa

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C

Efficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review

Mutations in INPP5K Cause a Form of Congenital Muscular Dystrophy Overlapping Marinesco-Sjögren Syndrome and Dystroglycanopathy

A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment

Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy

Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular Dystrophy

Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy

Suchergebnisse filtern